Dongsung Pharmaceutical Co., Ltd. (002210) - Financials, balance sheet (annual)

2,780 KRW

Last update May 7, 3:00 PM KST

Pre-market

Day range

2,780

Previous close

2,780

Open

2,780

Access this stock data via API

Dongsung Pharmaceutical Co., Ltd.

2,780.00

Financials

Balance sheet

Fiscal date	2024	2023	2022	2021
Total assets	151.9B	115.0B	107.7B	104.6B
Current assets	68.2B	60.8B	54.4B	50.0B
Cash	3.1B	6.4B	4.1B	3.1B
Cash equivalents	—	—	—	—
Cash and cash equivalents	3.1B	6.4B	4.1B	3.1B
Other short term investments	—	—	-300	2.0B
Accounts receivable	28.8B	29.2B	32.2B	27.7B
Other receivables	7.2B	2.1B	856.4M	198.8M
Inventory	22.7B	19.5B	14.9B	15.5B
Prepaid assets	7.5M	8.0M	8.9M	1.1B
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	222.6M	610.7M	67.2M	376.8M
Other current assets	6.1B	3.0B	2.2B	1.1K
Non current assets	83.8B	54.2B	53.3B	54.6B
Properties	937.2M	1.0B	4.8B	4.7B
Land and improvements	54.7B	24.8B	24.9B	18.1B
Machinery furniture equipment	2.2B	1.9B	17.8B	17.1B
Construction in progress	1.3B	154.1M	15M	127.8M
Leases	—	—	—	—
Accumulated depreciation	—	—	-32.1B	-29.4B
Goodwill	666.5M	978.8M	855.8M	942.7M
Investment properties	7.1B	7.3B	7.3B	14.8B
Financial assets	—	—	—	—
Intangible assets	666.5M	978.8M	855.8M	942.7M
Investments and advances	—	—	—	—
Other non current assets	2.2B	2.5B	589.2M	510
Total liabilities	96.7B	75.2B	64.9B	58.1B
Current liabilities	77.0B	44.8B	47.6B	37.6B
Accounts payable	12.0B	11.3B	9.9B	6.9B
Accrued expenses	—	—	—	—
Short term debt	51.4B	24.7B	29.3B	19.7B
Deferred revenue	—	—	—	—
Tax payable	—	—	418.8M	262.1M
Pensions	—	—	—	—
Other current liabilities	3.1B	2.8B	4.6B	3.7B
Non current liabilities	19.7B	30.3B	17.3B	20.6B
Long term provisions	—	—	—	—
Long term debt	646.9M	18.5B	7.8B	9.6B
Provision for risks and charges	3.5B	3.4B	3.4B	4.6B
Deferred liabilities	8.8B	3.2B	2.3B	1.8B
Derivative product liabilities	—	—	—	—
Other non current liabilities	390	-380	-200	520
Shareholders equity
Common stock	26.1B	26.1B	26.1B	26.1B
Retained earnings	-5.4B	-219.2M	1.2B	-2.6B
Other shareholders equity	—	—	—	—
Total shareholders equity	55.2B	39.8B	42.8B	46.4B
Additional paid in capital	20.8B	23.8B	25.5B	30.8B
Treasury stock	9.9B	9.9B	9.9B	7.9B
Minority interest	—	—	—	—